These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16465523)

  • 1. [Application of tissue microarrays for the diagnosis, prognosis and therapeutic decision making in renal cell carcinoma].
    Merseburger AS; Hennenlotter J; Schilling D; Sievert KD; Küfer R; Kuczyk MA
    Urologe A; 2006 Mar; 45(3):323-4, 326-7. PubMed ID: 16465523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Microarrays for the identification of molecular markers in the diagnosis and therapy of renal cell carcinomas].
    Sültmann H; Poustka A
    Urologe A; 2006 Mar; 45(3):297-8, 300-4. PubMed ID: 16465525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling of renal cell carcinoma and clinical implications.
    Rogers CG; Tan MH; Teh BT
    Urology; 2005 Feb; 65(2):231-7. PubMed ID: 15708028
    [No Abstract]   [Full Text] [Related]  

  • 4. [Papillary renal cell carcinoma and tumor biology. A multicenter project with "tissue microarray" (TMA)].
    Herrmann E; Wülfing C; Hartmann A
    Urologe A; 2007 Sep; 46(9):1175-6. PubMed ID: 17646959
    [No Abstract]   [Full Text] [Related]  

  • 5. Statistical methods for analyzing tissue microarray data.
    Liu X; Minin V; Huang Y; Seligson DB; Horvath S
    J Biopharm Stat; 2004 Aug; 14(3):671-85. PubMed ID: 15468758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Introduction to the topic: molecular biological elucidation of renal cell carcinoma].
    Küfer R; Hautmann R
    Urologe A; 2006 Mar; 45(3):295-6. PubMed ID: 16482464
    [No Abstract]   [Full Text] [Related]  

  • 7. [Identification of biomarkers and therapeutic targets for renal cell cancer using ProteinChip technology].
    Junker K; von Eggeling F; Müller J; Steiner T; Schubert J
    Urologe A; 2006 Mar; 45(3):305-6, 308, 310-12 passim. PubMed ID: 16491405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma.
    Yao M; Tabuchi H; Nagashima Y; Baba M; Nakaigawa N; Ishiguro H; Hamada K; Inayama Y; Kishida T; Hattori K; Yamada-Okabe H; Kubota Y
    J Pathol; 2005 Feb; 205(3):377-87. PubMed ID: 15682440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma].
    Slabý O; Svoboda M; Michálek J; Vyzula R
    Klin Onkol; 2009; 22(5):202-9. PubMed ID: 19886357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profiling of renal cancer: the journey to clinical application.
    Ribal MJ
    Eur Urol; 2011 May; 59(5):731-3. PubMed ID: 21296486
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances in molecular classification of renal neoplasms.
    Yin-Goen Q; Dale J; Yang WL; Phan J; Moffitt R; Petros JA; Datta MW; Amin MB; Wang MD; Young AN
    Histol Histopathol; 2006 Mar; 21(3):325-39. PubMed ID: 16372253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.
    Han G; Zhao W; Song X; Kwok-Shing Ng P; Karam JA; Jonasch E; Mills GB; Zhao Z; Ding Z; Jia P
    BMC Genomics; 2017 Oct; 18(Suppl 6):678. PubMed ID: 28984208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma.
    Moch H; Schraml P; Bubendorf L; Mirlacher M; Kononen J; Gasser T; Mihatsch MJ; Kallioniemi OP; Sauter G
    Am J Pathol; 1999 Apr; 154(4):981-6. PubMed ID: 10233835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Molecular stratification of clear cell renal cell carcinoma by consensus clustering reveals distinct subtypes and survival patterns.
    Taneja SS
    J Urol; 2011 Apr; 185(4):1224. PubMed ID: 22098953
    [No Abstract]   [Full Text] [Related]  

  • 15. [Molecular characterization of metastatic renal cell carcinomas. Differentiation of prognosis and therapy].
    Junker K; Sanjmyatav J; Heinze C; Walter M; Heinzelmann J; Wunderlich H; Schubert J; Steiner T
    Urologe A; 2008 Sep; 47(9):1187-9. PubMed ID: 18688592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
    Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
    Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transcriptome expression analyses of pulmonary renal cell carcinoma metastases].
    Wuttig D; Höfling C; Füssel S; Meinhardt M; Herr A; Tennstedt P; Holotiuk O; Baretton G; Meye A; Grimm MO; Rolle A; Wirth MP
    Urologe A; 2007 Sep; 46(9):1291-2. PubMed ID: 17619850
    [No Abstract]   [Full Text] [Related]  

  • 18. High expression of Solute Carrier Family 1, member 5 (SLC1A5) is associated with poor prognosis in clear-cell renal cell carcinoma.
    Liu Y; Yang L; An H; Chang Y; Zhang W; Zhu Y; Xu L; Xu J
    Sci Rep; 2015 Nov; 5():16954. PubMed ID: 26599282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular markers for predicting prognosis of renal cell carcinoma.
    Nogueira M; Kim HL
    Urol Oncol; 2008; 26(2):113-24. PubMed ID: 18312928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling of renal cell carcinoma and its implications in diagnosis, prognosis, and therapeutics.
    Takahashi M; Sugimura J; Yang X; Vogelzang N; Teh BS; Furge K; Teh BT
    Adv Cancer Res; 2003; 89():157-81. PubMed ID: 14587873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.